1 April 2021 in Journal Of Hypertension
Objective: We recently identified the physical interaction of a pattern recognition receptor (PRR), lectin-like oxidized LDL receptor with the GPCR, angiotensin II type 1 receptor (AT1) whereby oxLDL allosterically activates AT1. In this study, we investigated if AT1 physically interacts with another PRR, the receptor for AGE (RAGE), and ligands of RAGE could allosterically activate AT1. Design and method: We used normal rat kidney epithelial cells (NRK52E) to investigate the interaction of the endogenous receptors. We also generated five different genetically-engineered CHO cells to individually analyze the G protein and .β-arrestin pathways of AT1 activation; CHO cells expressing human RAGE (CHO-RAGE), CHO cells expressing both hRAGE and hAT1 (CHO-RAGE-AT1), CHO cells expressing both hRAGE and mutated hAT1 with impaired ability to activate G protein, and CHO cells expressing both hLOX-1 and mutated hAT1 with impaired ability to activate .β-arrestin Results: In NRK52E, AGE-BSA provoked the activation of MAP kinase (ERK) that was inhibited by ARB or siRNA of AT1 or RAGE. Activation of NfκB and Epithelial mesanchmal transition induced by AGE-BSA was inhibited by ARBs as well as RAGE inhibitor. In genetically engineered CHO-cells, in situ PLA assay and immunoprecipitation confirmed the physical interaction of AT1 and RAGE on cellular membrane. HMGB1, a RAGE ligand induced Gαi-dependent inhibition of cAMP production only in the presence of both RAGE and AT1 with intact G protein binding. The effect of HMGB1 on cAMP content was abolished by ARB as well as RAGE inhibitor. HMGB1 did not induce the accumulation of IP1, a downstream of Gαq signaling, in CHO cells expressing both AT1 and RAGE. Real-time imaging of cellular membrane revealed that RAGE induced endocytosis of LOX-1 that depends on the intact .β-arrestin pathway of AT1, and the phenomenon was not inhibited by ARB. Conclusions: RAGE ligands mediates cellular signaling via a physical interaction between RAGE and AT1. The activation of AT1 by RAGE ligands is distinct from that by angiotensin II in terms of selective G protein activation and the effect of ARB on G protein pathway but not on .β-arrestin pathway.
1 April 2021 in Journal Of Hypertension
Objective: Arrestin-dependent internalization of a G-protein-coupled receptor (GPCR) can intracellularly transport adjacent molecules. We previously proposed that a pattern recognition receptor (PRR), lectin-like oxidized LDL (oxLDL) receptor (LOX-1) physically interacts with the angiotensin II type 1 receptor (AT1) and the interaction mediates oxLDL-induced allosteric activation of AT1 and endothelial dysfunction. In this study, we analyzed direct downstream signaling pathways of AT1 by oxLDL, and investigated if the oxLDL-LOX-1 complex utilizes AT1-beta arrestin internalization to undergo endocytosis. Design and method: We used CHO-cells stably transfected with LOX-1 (CHO-LOX-1), AT1 (CHO-AT1), LOX-1 and AT1 (CHO-LOX-1-AT1), and LOX-1 and mutated AT1 that lacks ability to activate G protein or beta-arrestin pathway (CHO-LOX-1-mAT1). Activation of G(alpha)q and G(alpha)i were quantified by measuring the accumulation of IP1 and the inhibition of forskolin-induced cAMP production, respectively. Endocytosis of the oxLDL-LOX-1 complex through the AT1-beta-arrestin pathway was detected by an AT1-beta-arrestin BRET assay, real-time imaging of the membrane dynamics of LOX-1, and visualization of endocytosis of oxLDL. Endocytosis of oxLDL was assessed by the quantification of fluorescent intensity in cells with treatment and subsequent washout of Dil-labelled oxLDL. Results: Using genetically modified CHO cells, we found that oxLDL induced G(alpha)i-dependent inhibition of cAMP production only in the presence of both LOX-1 and AT1 with intact G protein binding. In contrast, oxLDL did not induce the accumulation of IP1, a downstream of G(alpha)q signaling, in CHO cells expressing both AT1 and LOX-1. The BRET signal between AT1-beta-arrestin was exerted by oxLDL only in the presence of LOX-1. Real-time imaging of cellular membrane revealed that oxLDL induced endocytosis of LOX-1 that depends on the intact beta-arrestin pathway of AT1. oxLDL accumulated in CHO cells expressing both LOX-1 and AT1 more prominently than those expressing LOX-1 or AT1 alone. This enhanced accumulation depended on the beta-arrestin-binding potency of AT1, and was abolished by dominant-negative or pharmacological inhibition of beta-arrestin. Accumulation of oxLDL was similarly attenuated by knockdown of AT1, beta-arrestin or LOX-1 in human vascular endothelial cells. Conclusions: oxLDL triggers selective G protein activation and beta-arrestin-dependent internalization of AT1 whereby the oxLDL-LOX-1 complex undergo endocytosis.